Stockreport

Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma [Yahoo! Finance]

Adicet Bio, Inc.  (ACET) 
Last adicet bio, inc. earnings: 5/3 05:00 pm Check Earnings Report
US:NASDAQ Investor Relations: aceto.com/ir/index.html
PDF Company expects to share preliminary Phase 1 clinical data in the first half of 2025 REDWOOD CITY, Calif. & BOSTON, December 19, 2024 BUSINESS WIRE )--Adicet Bio, Inc [Read more]